Medium NAPLEX Beyond Use Date Practice Questions

Concept Explanation

A Beyond Use Date (BUD) is the date or time after which a compounded preparation shall not be used, and it is determined from the date the preparation is compounded. Unlike manufacturer expiration dates, which are determined after extensive stability testing for commercial products, BUDs are assigned by pharmacists based on the USP General Chapter <795> for non-sterile preparations and USP General Chapter <797> for sterile preparations. Mastering these standards is a critical component of NAPLEX Prep, as it ensures patient safety by preventing the administration of degraded or contaminated medications.

For non-sterile compounding (USP 795), the default BUDs are categorized by the formulation's water activity and preservative content:

• Nonaqueous Formulations: 180 days (stored at controlled room temperature or refrigerated).
• Water-Containing Oral Formulations: 14 days (must be refrigerated).
• Water-Containing Topical/Dermal and Mucosal Formulations: 30 days (stored at controlled room temperature or refrigerated).

For sterile compounding (USP 797), BUDs are determined by the risk level (Category 1 or 2) and the storage conditions (Room Temperature, Refrigerated, or Frozen). Category 1 products are typically prepared in a Segregated Compounding Area (SCA) and have shorter BUDs (e.g., 12 hours at room temperature), while Category 2 products are prepared in a cleanroom suite and allow for longer dating. Understanding these distinctions is as vital as mastering Medium NAPLEX Infectious Disease Practice Questions, where sterile preparation integrity directly impacts treatment outcomes.

Solved Examples

1. Problem: A pharmacist compounds an oral suspension of spironolactone using crushed tablets and a flavored syrup containing water. The preparation is made on October 1st. What is the maximum BUD, and where should it be stored?
   Solution:
   1. Identify the formulation type: This is a water-containing oral formulation.
   2. Apply USP 795 standards: Water-containing oral formulations have a maximum BUD of 14 days.
   3. Calculate the date: October 1 + 14 days = October 15.
   4. Determine storage: These formulations must be refrigerated.
   5. Answer: October 15; Refrigerated.
2. Problem: A pharmacist prepares a topical cream by incorporating a drug powder into a commercial moisturizing base that contains water. The compounding occurs on May 10th. What is the BUD?
   Solution:
   1. Identify the formulation type: This is a water-containing topical/dermal formulation.
   2. Apply USP 795 standards: Water-containing topical formulations have a maximum BUD of 30 days.
   3. Calculate the date: May 10 + 30 days = June 9.
   4. Answer: June 9.
3. Problem: An IV admixture is prepared in a laminar airflow workbench located within an ISO 7 cleanroom (Category 2). If the preparation is stored in the refrigerator, what is the maximum BUD according to USP 797 (assuming no sterility testing)?
   Solution:
   1. Identify the category: Category 2 sterile preparation.
   2. Determine storage condition: Refrigerated.
   3. Apply USP 797 standard: For Category 2 preparations (aseptically processed, no sterility test, only sterile starting components), the refrigerated BUD is 10 days.
   4. Answer: 10 days.

Practice Questions

1. A pharmacist compounds a progesterone vaginal suppository using a nonaqueous polyethylene glycol (PEG) base. If the preparation is compounded on January 15, what is the latest possible BUD?

2. A 2% lidocaine gel is prepared using purified water and a thickening agent. The preparation is intended for mucosal application. What is the maximum BUD for this compound?

3. A technician prepares a batch of vancomycin IV bags in a Segregated Compounding Area (Category 1). If the bags are stored at room temperature, what is the maximum BUD?

4. An anhydrous ointment is prepared by mixing mineral oil and petrolatum with a drug powder. If the ingredients have expiration dates of 2 years from now, what BUD should be assigned to the compound?

5. A pharmacist is preparing a Category 2 sterile injectable using only sterile ingredients. If the product will be stored in a freezer at $-20^{\circ}\ \text{C}$, what is the maximum BUD permitted by USP 797?

6. You are compounding an oral solution of Morphine Sulfate 2 mg/mL using simple syrup (containing water). If the compounding date is July 4th, when does the preparation expire, and what are the storage requirements?

7. A sterile ophthalmic drop is compounded in an ISO 5 PEC located in an ISO 7 buffer room. The pharmacist uses non-sterile bulk powder to create the solution, which is then terminally sterilized. What is the refrigerated BUD for this Category 2 preparation?

8. A multi-dose vial (MDV) of insulin is punctured for the first time on September 1. According to general practice standards, what is the BUD for this vial if stored at room temperature?

9. A pharmacist compounds an oral suspension using a commercially available vehicle (Ora-Plus/Ora-Sweet). The manufacturer label on the vehicle states it contains water. What is the max BUD?

10. During a shortage, a pharmacist prepares a batch of hand sanitizer containing 75% isopropyl alcohol and no water. What is the BUD for this nonaqueous formulation?

Answers & Explanations

1. Answer: July 14 (180 days). Progesterone in a PEG base is considered a nonaqueous formulation. Under USP 795, nonaqueous formulations are assigned a BUD of 180 days when stored at room temperature or refrigerated.
2. Answer: 30 days. This is a water-containing mucosal (topical) formulation. USP 795 limits water-containing topical/mucosal preparations to a 30-day BUD.
3. Answer: 12 hours. Category 1 sterile preparations, which are typically compounded in a Segregated Compounding Area (SCA) rather than a full cleanroom suite, are limited to a BUD of 12 hours at room temperature or 24 hours if refrigerated.
4. Answer: 180 days. Anhydrous ointments are nonaqueous formulations. Even if the ingredients expire in 2 years, the USP 795 default BUD for a nonaqueous compound is 180 days.
5. Answer: 45 days. For Category 2 sterile preparations compounded with sterile components and aseptically processed, the BUD when stored frozen ($-25^{\circ}\ \text{C}$ to $-10^{\circ}\ \text{C}$) is 45 days.
6. Answer: July 18; Refrigerated. This is a water-containing oral formulation. July 4 + 14 days = July 18. USP 795 requires these to be refrigerated. This is as essential to safety as monitoring for Medium NAPLEX Anticoagulation Practice Questions.
7. Answer: 28 days. For Category 2 preparations that are terminally sterilized (even if starting with non-sterile components), the refrigerated BUD is 28 days.
8. Answer: 28 days. While not a compounded BUD in the same sense as USP 795/797, the standard BUD for a punctured multi-dose vial is 28 days unless otherwise specified by the manufacturer.
9. Answer: 14 days. Because the vehicle contains water and the final product is for oral use, it falls under the 14-day refrigerated rule. You can practice similar calculations using the AI Question Generator.
10. Answer: 180 days. Nonaqueous formulations (liquids or solids) have a default BUD of 180 days under the updated USP 795 guidelines.

1. What is the maximum BUD for a water-containing oral formulation stored in the refrigerator according to USP 795?

• A7 days
• B14 days
• C30 days
• D180 days

Frequently Asked Questions

What is the difference between an expiration date and a BUD?

An expiration date is determined by the manufacturer based on stability studies of a specific commercial product in its original packaging. A Beyond Use Date (BUD) is assigned by a pharmacist to a compounded preparation or a repackaged drug, representing the date after which the preparation should not be used due to potential instability or contamination.

Can a BUD exceed the expiration date of an ingredient?

No, the BUD of a compounded preparation can never exceed the shortest expiration date of any individual component used in the compound. If an ingredient expires in 10 days, the BUD of the final preparation must be 10 days or less, even if the USP default would normally allow for longer.

What qualifies as a "nonaqueous" formulation under USP 795?

A nonaqueous formulation is any preparation that does not contain water, such as a drug incorporated into an oil base, a PEG-based suppository, or a capsule containing only dry powders. These formulations are generally more stable and are granted the longest BUD of 180 days.

How does USP 797 define Category 1 and Category 2 sterile preparations?

Category 1 CSPs are those prepared in an environment that may not meet all cleanroom suite requirements, such as a segregated compounding area (SCA), and consequently have shorter BUDs. Category 2 CSPs are prepared in a full cleanroom suite (ISO 7 buffer room and ISO 8 anteroom) and are subject to more stringent environmental monitoring, allowing for longer BUDs.

Are BUDs for sterile products different if they undergo sterility testing?

Yes, if a Category 2 sterile preparation undergoes and passes a validated sterility test according to USP <71>, the BUD can be extended significantly beyond the default limits. For example, a refrigerated Category 2 preparation that passes sterility testing may be assigned a BUD of up to 60 or 90 days depending on the method of sterilization.